SCHEMBL321887

SCHEMBL321887

CCC(O)N(O)C(O)CC

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29233004 0.84
SCHEMBL8743481 0.79
SCHEMBL7595174 0.78 TDP1 (0.30) TSHR
SCHEMBL27647950 0.76
SCHEMBL10629420 0.74 TSHR (0.44) TSHR
SCHEMBL11045664 0.74 TSHR (0.44) TSHR
SCHEMBL37604 0.74 TSHR (0.44) TSHR
SCHEMBL9403632 0.73 TSHR (0.35) TSHR
SCHEMBL28137145 0.73
Hydrochloric Acid SCHEMBL27668450 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049180-A1 FAST CURING, STICKY POLYMERS FOR MEDICAL USES UNIV CALIFORNIA (US) 2026-02-19 US claimed
US-12269925-B1 Fast curing, biocompatible and biodegradable adhesives and sealants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-08 US claimed
EP-2744833-B1 INHIBITOR COMPOSITIONS AND METHODS OF USE NUFARM UK LTD (GB) 2016-09-28 EP claimed
US-9133288-B2 Retarder composition NUFARM UK LIMITED (GB) 2015-09-15 US claimed
US-20140194559-A1 Novel Inhibitor Compositions and Methods of Use NUFARM UK LIMITED (GB) 2014-07-10 US claimed
EP-2744833-A1 NOVEL INHIBITOR COMPOSITIONS AND METHODS OF USE Nufarm UK Limited (GB) 2014-06-25 EP claimed
EP-2590914-B1 RETARDER COMPOSITION NUFARM UK LTD (GB) 2014-06-11 EP claimed
EP-2590914-A1 RETARDER COMPOSITION Nufarm UK Limited (GB) 2013-05-15 EP claimed
US-20130116486-A1 Retarder Composition NUFARM UK LIMITED (GB) 2013-05-09 US claimed
WO-2013027042-A1 NOVEL INHIBITOR COMPOSITIONS AND METHODS OF USE NUFARM UK LIMITED (GB) 2013-02-28 WO claimed
WO-1998004646-A1 CHEMICAL MECHANICAL POLISHING COMPOSITION AND PROCESS EKC TECHNOLOGY, INC. (US) 1998-02-05 WO claimed
US-5648573-A BENZOQUINONE DERIVATIVE, HYDROXYLAMINE COMPOUND BETZDEARBORN INC. (US) 1997-07-15 US claimed
US-5648572-A DINITROSALICYLIC ACID OR ESTER, HYDROXYLAMINE DERIVATIVE BETZDEARBORN INC. (US) 1997-07-15 US claimed
EP-0594341-B1 Compositions and methods for inhibiting vinyl aromatic monomer polymerization BETZ EUROP INC (US) 1997-01-22 EP claimed
WO-1996041783-A1 TREATMENTS FOR INHIBITING VINYL AROMATIC MONOMER POLYMERIZATION BETZDEARBORN INC. (US) 1996-12-27 WO claimed
WO-1996038399-A1 TREATMENTS FOR INHIBITING VINYL AROMATIC MONOMER POLYMERIZATION BETZDEARBORN INC. (US) 1996-12-05 WO claimed
US-5489718-A MIXTURE OF AN OXIME COMPOUND AND A HYDROXYLAMINE COMPOUND BETZ LABORATORIES, INC. (US) 1996-02-06 US claimed
EP-0690117-A2 Compositions and methods for inhibiting vinyl aromatic monomer polymerization BETZ EUROPE, INC. (US) 1996-01-03 EP claimed
US-5426257-A Adding an oxime compound and a hydroxylamine compound BETZ LABORATORIES, INC. (US) 1995-06-20 US claimed
US-5282957-A Methods for inhibiting polymerization of hydrocarbons utilizing a hydroxyalkylhydroxylamine BETZ LABORATORIES, INC. (US) 1994-02-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116486-A1 Retarder Composition NQO1, NQO2, ALOX5 TSHR 4147/4885
US-20260049180-A1 FAST CURING, STICKY POLYMERS FOR MEDICAL USES ILK, VCL, PTK2 TSHR 2114/4885
US-20140194559-A1 Novel Inhibitor Compositions and Methods of Use NQO1, NQO2, ABCG2 TSHR 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.